Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.80 +0.56 (+3.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025)

Updated

Syndax Pharmaceuticals (SNDX) reported Capital Expenditures of $56,000 for Q4 2025, down 57.3% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025) Analysis & Trends

For FY2025, Syndax Pharmaceuticals posted Capital Expenditures of $187,000.

  • Capital Expenditures has a four-year compound annual growth rate of 9.7% (FY2021 to FY2025).
  • By year, Capital Expenditures came in at $129,000 in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Capital Expenditures since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 56,000.00
Sep 30, 2025 131,000.00
Dec 31, 2018 14,000.00
Mar 31, 2018 173,000.00
Dec 31, 2017 42,000.00
Sep 30, 2016 55,000.00
Jun 30, 2016 73,000.00
Mar 31, 2016 133,000.00
Dec 31, 2015 31,000.00
Sep 30, 2015 13,000.00
API Access

Syndax Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SNDX&period=max&api_key=YOUR_API_KEY